US OptionsDetailed Quotes
TGTX250502P40000
- 0.05
- -0.70-93.33%
15min DelayClose Apr 30 16:00 ET
0.15High0.05Low
0.15Open0.75Pre Close63 Volume166 Open Interest40.00Strike Price810.00Turnover160.19%IV12.22%PremiumMay 2, 2025Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.1032Delta0.0369Gamma182.04Leverage Ratio-0.2229Theta-0.0002Rho-18.78Eff Leverage0.0054Vega
TG Therapeutics Stock Discussion
Game-Changing MS Treatment? BRIUMVI Single-Dose Trial Reveals Breakthrough Potential
Game-Changing MS Treatment: BRIUMVI Reveals Exceptional Real-World Safety Profile
Medical Journals Reveal Breakthrough: BRIUMVI Succeeds Where Other MS Treatments Fall Short
How TG Therapeutics Transformed from Clinical-Stage to Profitable Biotech with 250% Revenue Growth
Can BRIUMVI Succeed Where Other MS Treatments Failed? New Clinical Data Reveals Promising Results
Larger Image: tradingview.com...
$TG Therapeutics (TGTX.US)$
No comment yet